41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Editorial Commentary: Where to Place the New Treatments for Clostridium difficile Infection?

      editorial

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Clin Infect Dis
          Clin. Infect. Dis
          cid
          cid
          Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
          Oxford University Press
          1058-4838
          1537-6591
          15 September 2016
          30 June 2016
          15 September 2017
          : 63
          : 6
          : 735-736
          Affiliations
          [1 ] Department I of Internal Medicine and Center for Integrated Oncology CIO Köln/Bonn, University Hospital of Cologne
          [2 ] German Centre for Infection Research , Partner Site Bonn-Cologne
          [3 ] Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, and Clinical Trials Center Cologne, ZKS Köln, University of Cologne , Germany
          Author notes
          Correspondence: O. A. Cornely, Department I of Internal Medicine and Center for Integrated Oncology CIO Köln/Bonn, University Hospital of Cologne, 50937 Cologne, Germany ( oliver.cornely@ 123456uk-koeln.de ).
          Article
          PMC4996134 PMC4996134 4996134 ciw366
          10.1093/cid/ciw366
          4996134
          27365386
          18f13740-92db-4cdc-9a37-b34f3b0e08bb
          © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
          History
          : 24 May 2016
          : 26 May 2016
          Funding
          Funded by: NIH;
          Award ID: UM1AI104681
          Categories
          Articles and Commentaries

          fidaxomicin,bezlotoxumab,recurrence,treatment pathway, Clostridium difficile

          Comments

          Comment on this article